July 7, 2011
An MS Patients’ Story – Stu’s Updated story
- /
- /
For a change of Pace, allow me to give a brief essay concerning me and my MS How I first find out…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
July 7, 2011
Multiple Sclerosis Not Aided by Breast-Feeding
- /
Posted by Alex Heigl on July 6, 2011 Multiple sclerosis relapses cannot be staved off by breast-feeding. Researchers working at the…
July 6, 2011
Regenerative Medicine (Myelin Repair) in MS: Where are we today?
- /
- /
July 5, 2011 By Cherie C. Binns RN BS MSCN Several weeks ago, I was asked by Stuart to get…
July 6, 2011
Unilabs to Develop Companion Dx for Biogen Idec Drug
- /
- /
July 6, 2011 By a GenomeWeb staff reporter NEW YORK (GenomeWeb News) – Unilabs will develop a companion diagnostic assay for…
July 4, 2011
Why does autoimmune disease strike women more often then men?
- /
- /
July 4, 2011 Researchers at National Jewish Health have discovered a type of cell that may contribute to autoimmune disease.…
July 4, 2011
Fingolimod Study for PPMS
- /
Fingolimod PPMS– Oral Pill Study Sponsored by Novartis for the … This study is a 3 year multi-center study comparing the safety and efficacy of fingolimod in patients with…
July 4, 2011
MS Update: Biogen Idec Researchers Identify Novel Approach for Promoting Remyelination
- /
July 03, 2011 Biogen Idec Researchers Identify Novel Approach for Promoting Remyelination and Inhibiting Autoimmune Activation as Potential Therapeutic Option…
July 4, 2011
Fast Forward, LLC and EMD Serono Provide funding of Over $1 Million to Accelerate Early Stage Research in MS
- /
- /
New York, NY, JUNE 30, 2011 – Fast Forward, LLC, a not-for-profit organization established by the National Multiple Sclerosis Society and…
July 2, 2011
MSAA’s new mobile phone application
- /
My MS Manager Welcome to My MS Manager – MSAA’s new mobile phone application, provided free of charge to individuals with multiple…
July 1, 2011
Laquinimod: The next oral agent for multiple sclerosis?
- /
Key point: According to a Phase III trial of the once-daily, investigational immunomodulatory laquinimod, this agent significantly reduced annualized relapse rate,…
